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Glossary of Terms 
Association for Professionals in Infection Control (API C): A board of professionals elected to 
improve health and patient safety by reducing risks of infection and other adverse outcomes. Its 
members include nurses, epidemiologists, physicians, quality and patient safety professionals, 
healthcare executives, microbiologists, clinical pathologists, laboratory technologists, and public 
health practitioners. API C advances its mission through education, research, consultation, 
collaboration, public policy, practice guidance and credentialing. 
Centers for Disease Control and Prevention (CDC): A division of the Department of Health 
and Human Services collaborating to create the expertise, information, and tools that people and 
communities need to protect their health through health promotion, prevention of disease, injury 
and disability, and preparedness for new health threats. 
Healthcare Infection Control Practices Advisory Committee (HICP A C): A federal advisory 
committee made up of 14 external infection control experts who provide advice and guidance to 
the Centers for Disease Control and Prevention (CDC) and the Secretary of the Department of 
Health and Human Services (HHS) regarding the practice of health care infection control, 
strategies for surveillance and prevention and control of health care associated infections in 
United States health care facilities. 
Institute for Healthcare Improvement (IHI): An independent not-for-profit organization 
helping to lead the improvement of health care throughout the world. Founded in 1991 
and based in Cambridge, Massachusetts, IHI works to accelerate improvement by building the 
will for change, cultivating promising concepts for improving patient care, and helping health 
care systems put those ideas into action. 
Methicillin-Resistant Staphylococcus aureus (MRSA): A bacteria prevalent in many hospitals 
and communities that is resistant to many antibiotics and difficult to treat. 
Multidrug Resistant Organism (MDRO): A bacterium such as MRSA that is resistant to many 
antibiotics. 
Society for Healthcare Epidemiology of America (SHEA): Organized in 1980 to foster the 
development and application of the science of healthcare epidemiology. SHEA focuses on a 
variety of disciplines and activities directed at prevention and control of infections and adverse 
outcomes, as well as enhancing the quality-of-care. 
World Health Organization (WHO): The directing and coordinating authority for public health 
within the United Nations system. The WHO is responsible for providing leadership on global 
health matters, shaping the health research agenda, setting norms and standards, articulating 
evidence-based policy options, providing technical support to countries and monitoring and 
assessing health trends. 
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Abstract 
One third of all people in America walk around with staphylococcus germs in their noses. Two 
and a half million people carry the strain of staphylococcus called methicillin-resistant 
Staphylococcus aureus (MRSA) that most antibiotics can't kill. MRSA is one of the fastest 
growing pathogens known today. The United States has the world's second highest rate of 
MRSA infections, and it continues to rise. As awareness and incidence of MRSA has increased, 
a call for mandatory test cultures has grown. While these tests are crucial to controlling MRSA, 
mandating them puts undue burden on hospitals when a well-tested series of steps has proven 
extremely effective in preventing the spread of the deadly bacteria. With the increase of 
healthcare associated MRSA infections, much of the research over the past ten years has been 
devoted to uncovering strategies to reduce the incidence within the healthcare setting. Studies 
have shown that healthcare institutions can greatly reduce the incidence of MRSA by instituting 
the following five components of care: I) Hand hygiene 2) Decontamination of the environment 
and equipment 3) Active surveillance 4) Contact precautions for infected and colonized patients 
5) Central line and ventilator device bundles. Many researchers and organizations are also 
evaluating whether mandatory active surveillance cultures (ASCs) will reduce its incidence. 
Leaders in infection control organizations do not support mandating ASCs, but do support the 
practice as an effective way to reduce the transmission of MRS A. As infection control leaders it 
is imperative to recognize the differences in needs and resources within healthcare institutions 
throughout the United States. By mandating ASCs many healthcare institutions are obligated to 
utilize resources on ASCs that might be better used in education of staff and the community. 
Research has proven the effectiveness of the five components of care in the reduction of MRS A. 
However, to what extent and how these five components of care are implemented should be left 
Reducing MRSA 5 
up to each individual healthcare institution as to how it best fits their needs. This paper will 
discuss the evidence-based five components to reduce MRSA and give healthcare providers the 
knowledge to implement them within their individual healthcare institutions. 
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What is MRSA? 
Bacteria have existed for billions of years. Whether it's the result of naturally occurring 
antibacterials in the human body or the new generation of manmade antibiotics, bacteria have 
found ways to survive, mutate, multiply and evolve, and in tum have become resistant to many 
available treatments. 
Researchers believe that bacteria began developing resistance to antibiotics in the 1940s, 
just a few years after Alexander Fleming's discovery of penicillin. After the introduction of 
methicillin in the 1960s, staphylococcus (staph) bacteria began developing increasing resistance. 
Its path is similar to that of penicillin: In 1950 penicillin was effective against 100 percent of 
staph strains. By 1985 it was effective against less than five percent of staph strains (Institute for 
Healthcare Improvement, 2007). Today MRSA, also known as a multidrug-resistant organism 
(MDRO), is not only resistant to penicillin, but to many other antibiotics as well. As a result of 
its resistance to multiple antibiotics MRSA has been labeled a super bug. According to the 
Centers for Disease Control and Prevention (CDC) (2007), the proportion ofhealthcare-
associated staph infections due to MRSA rose from two percent in 197 4 to 22 percent in 1995 to 
64 percent in 2004 in US Intensive Care Units (ICUs). 
Once MDROs are introduced into the healthcare setting, transmission and persistence of 
the resistant strain is determined by the availability of vulnerable patients, selective 
pressure exerted by antimicrobial use, increased potential for transmission from larger 
numbers of colonized or infected patients, and the impact of implementation and 
adherence toprevention efforts (CDC, 2006, p. 8). 
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MRSA colonization occurs when colonies of the bacteria grow in the nasal passages and 
folds of the skin, but the person is asymptomatic. Other common areas of colonization are the 
perineal or inguinal areas, the axillae, trunk, and upper extremities (CDC, 2002). Some patients 
come into the hospital already colonized with MRSA having acquired it in the community or 
from previous contact with the healthcare system- whether it's another hospital, nursing home, or 
rehabilitation facility. Patients colonized with MRSA are at greater risk of developing a clinical 
infection. This includes those with severe disease, especially those who are 
immunocompromised; those with invasive devices such as central lines and ventilators; and 
patients who have undergone recent surgery (CDC, 2006). Nearly one-third of patients newly 
colonized with MRSA in an ICU setting developed invasive disease within 18 months, with 
approximately 50 percent of these infections occurring after discharge, often resulting in 
readmission (Huang et a!., 2006). 
Community-acquired MRSA (CA-MRSA) has become a global problem of epidemic 
proportions. The CDC reports that eight to 20 percent of MRSA infections are found in the 
community (Holcomb, 2006). The populations most affected by CA-MRSA are children, 
parenteral drug users, men who have sex with men, military personnel, prisoners, and certain 
ethnic populations (Cohen, 2007). Recently, athletes that participate in competitive contact sports 
have also been identified to be at greater risk of developing CA-MRSA. Historically, the strains 
of MRSA found in the community setting are epidemiologically distinct from those found in the 
healthcare setting. The community isolates are resistant to fewer antibiotics than its healthcare 
acquired counterparts. This decrease in multidrug resistance has been attributed to a novel mecA 
gene found in CA-MRSA strains (Rihn, Michaels, & Harner, 2005). CA-MRSA most 
commonly presents as a minor skin and soft tissue infection, and is most often described to the 
Reducing MRSA 8 
physician as a spider bite. At times, particularly in children, CA-MRSA can result in admission 
to a healthcare facility, introducing these unique CA-MRSA strains to the healthcare community 
and furthermore increasing the risk of transmission throughout the hospital setting. 
Inevitably, with an increase in community-acquired MRSA there has been an increase in 
MRSA in healthcare institutions with more and more patients admitted to the hospital already 
infected or colonized with MRSA. Now, with Medicare withholding reimbursement for many 
hospital acquired infections it is imperative that healthcare institutions differentiate between 
MRSA infections and colonizations that were acquired in the hospital as opposed to pre-existing 
conditions. As a result, many healthcare institutions are performing ASC's upon admission to 
determine if it is a pre-existing condition. In addition, health care institutions are instituting five 
components of care to reduce the incidence of acquiring MRSA while in the hospital. 
The Five Components of Care 
In 2006, The Institute for Healthcare Improvement (IHI) launched its 5 Million Lives 
Campaign. Its objective/goal is to protect patients from five million incidents of medical harm 
from December 2006 to December 2008. 
The IHI defines "medical harm" as the unintended physical injury resulting from or 
contributed to by medical care (including the absence of indicated medical treatment), 
that requires additional monitoring, treatment or hospitalization, or that results in death. 
Such injury is considered harm whether or not it is considered preventable, resulted from 
a medical error, or occurred within a hospital (IHI, n.d.). 
This campaign challenges American hospitals to adopt twelve changes that save lives and reduce 
patient injury. One of these changes is to reduce MRSA infection by implementing scientifically 
proven infection prevention practices. The IHI believes that the prevention of MRSA 
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transmission requires a multifaceted approach comprised of five components of care: 1) hand 
hygiene 2) decontamination of the environment and equipment 3) active surveillance 4) contact 
precautions for infected and colonized patients 5) central line and ventilator device bundles. Each 
plays a key role in controlling the spread of the bacteria. 
Hand Hygiene 
For many generations hand washing has been considered a measure of good personal 
hygiene. As a result of early studies conducted by Ignaz Semmelweis and Oliver Wendell 
Holmes, the CDC, the World Health Organization (WHO), the Association for Professionals in 
Infection Control (API C), and the Healthcare Infection Control Practices Advisory Committee 
(HICPAC) have written hand hygiene guidelines. Despite subtle differences, all of the above 
organizations are in agreement that hand hygiene is the most important measure to reduce the 
spread of infection in healthcare facilities. 
Normal human skin is colonized with transient and resident bacteria. Transient flora, 
which colonize the superficial layers of the skin and are most frequently related to healthcare 
associated infections, are often acquired by HCWs during direct contact with patients or 
contaminated surfaces close to patients. These bacteria are easily removed by routine hand 
hygiene. Resident flora within the deeper layers of skin, are more difficult to remove, and are 
less likely associated with healthcare associated infections (Centers for Disease Control and 
Prevention, 2002). 
The transmission ofMRSA from one patient to another most often occurs via the 
contaminated hands, clothing, and equipment of health care workers (HCWs) (Institute for 
Healthcare Improvement, 2008). Hands are easily contaminated during patient care by coming in 
contact with the colonized or infected patient, or the environmental surfaces the patient has 
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touched. MRSA can survive for days and sometimes even months on inanimate objects such as 
phones, computer keyboards, bedside tables, and bed rails. 
Hospitalized patients are colonized with MRSA most frequently in their nose, but other 
body sites with high concentration are their skin, throat, rectum, and ostomies (Institute for 
Healthcare Improvement, 2008). Between 30 to 60% of healthy adults are colonized with 
Staphylococcus aureus and I 0% to 20% are chronically colonized, mostly in their nares 
(Henderson, 2006). The risk of transmission ofMRSA can be greatly decreased through proper 
hand hygiene, either hand washing with soap and water or utilizing a waterless, alcohol-based 
hand rub. 
The CDC defines hand hygiene as either washing with soap and water or using a 
waterless, alcohol-based hand rub. There are certain indications for handwashing over an 
alcohol-based hand rub. These include when hands are visibly soiled, when caring for a patient 
with Clostridium difficile, before eating, and after using the restroom. Otherwise, alcohol-based 
hand rubs should be the product of choice for hand hygiene. 
Over the last several years many studies have proven that alcohol-based products are 
more effective in reducing MRSA from the hands ofHCWs than soap and water because they 
are rapidly active and have a broad antimicrobial spectrum (Henderson, 2006). However, 
compliance rates of hand hygiene by HCWs often fall below 50% in many healthcare 
institutions. There are many factors that have been attributed to low compliance rates by HCWs 
including skin irritation associated with frequent handwashing, inaccessibility to hand hygiene 
supplies such as the waterless alcohol-based hand rubs, lack of hand hygiene facilities, lack of 
education about the importance of hand hygiene and how hands become contaminated, high 
workloads and understaffing (not enough time), and lack of commitment to hand hygiene by 
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institutions (Pittet & Boyce, 2002). Many of these factors can be reduced by using alcohol-based 
hand rubs because not only are they more effective, but they require less time to use, are easy to 
make accessible during patient care, and cause less skin irritation and drying (Institute for 
Healthcare Improvement, 2006). 
It is important to emphasize that failure to use an appropriate volume of alcohol-based 
hand rub or soap for a sufficient length of time will result in an ineffective reduction of 
pathogens from HCWs' hands. A sufficient amount of alcohol-based hand rub will allow for 
hands to be rubbed together with friction for at least 15 seconds before they are dry or before 
rinsing (Institute for Healthcare Improvement, 2006). 
According to the IHI (2006), instituting a multifaceted hand hygiene program to improve 
compliance that includes increasing the accessibility of alcohol-based hand rubs and 
implementing educational and behavioral initiatives will decrease incidence rates of MRSA. 
Many institutions have found that placing alcohol-based hand rub dispensers adjacent to patient 
beds has increased hand hygiene compliance. Educational and behavioral initiatives can include 
programs demonstrating proper hand hygiene technique, encouraging patients and families to 
advocate for their safety by asking staff to perform hand hygiene before and after caring for 
them, providing interactive lectures given by knowledgeable professionals about the importance 
of hand hygiene, and hanging posters and distributing buttons to staff which will serve as a 
constant reminder. All of these initiatives will help make hand hygiene a part of an institution's 
culture and make compliance the social norm. A hospital in Geneva, Switzerland had an increase 
in hand hygiene compliance from 48% in 1994 to 66% in 1997 after initiating a campaign that 
included posters on hand hygiene and installation of alcohol-based hand rub dispensers by the 
patient's bedsides (Institute for Healthcare Improvement, 2008). 
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Decontamination of the Environment and Equipment 
MRSA survives well in the hospital environment, which creates concern over the state of 
its cleanliness. Times have changed over the years; there are differences in the types of patients 
and the clinical environments in which they are cared for. Today, patients are older, 
immunologically weaker, and are subjected to more invasive procedures and devices (Dancer, 
2007). Also, over the past several decades there has been a large increase in the amounts and 
types of electronic equipment that patients come in contact with that require a greater degree of 
disinfection and cleaning. Staphylococcus has become the most common bacterial pathogen 
worldwide, which creates concern with the increase of resistant staphylococcus and the decrease 
in the amount of antimicrobial agents there are to treat it (Dancer, 2007). 
The transmission cycle ofMRSA most often occurs via the hands ofhealthcare workers 
either from direct contact with a patient colonized or infected with MRSA or the surfaces the 
patient touches. The potential for MRSA to be transmitted to patients via environmental surfaces 
depends on many factors, including its ability to remain viable on a variety of dry surfaces, the 
frequency in which these surfaces are touched by HCWs and patients, and how high the levels of 
contamination are (Boyce, 2007). Environmental contamination usually occurs during routine 
patient care. Direct contact with the infected or colonized patient does not have to occur to 
contaminate the hands of healthcare workers. In fact, studies have demonstrated that MRSA can 
survive on room surfaces for days, weeks, and months, even after discharge cleaning (Goodman 
et al, 2008). It can remain virulent and capable of causing infection after exposure to dry surfaces 
for at least 1 0 days (Boyce, 2007). There is much evidence that supports the contaminated hands 
ofHCWs from the environment are a common mode of transmission to other patients. Studies 
have also proven MRSA contaminated environments as the main cause of outbreaks, which were 
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not brought under control until the environment was thoroughly cleaned. According to Hardy et 
al (2006) MRSA was isolated from the environment at every environmental screening within an 
ICU setting. Overall, MRSA was present in 21.8% of the environmental samples with the highest 
level of contamination found underneath the beds followed by workstations, monitors, and 
ledges behind the beds. The sites underneath the beds have been noted in various studies to have 
the highest level of contamination because it is not far from the floor (Hardy et al, 2006). 
Although hands infrequently touch the floors, the transmission of MRSA occurs through the 
movement of dust in the air to the more frequently touched snrfaces (Shiomori et al, 2002). 
Another study by Otter et al, (2006) showed the highest level of MRSA was recovered most 
frequently from the bedside rails (100% of those cultured); followed by blood pressure cuffs, 
television remotes, bedside tables, toilet seats, door handles, and intravenous pumps. Whenever 
possible, equipment used on patients with MRSA should be disposable. However, when that is 
not an option, disinfection of such equipment with 70% isopropyl alcohol has been shown to 
significantly decrease bacterial counts (Society for Healthcare Epidemiology of America, 2003). 
Regardless of where the highest level of contamination occurs, it is evident that MRSA survives 
on surfaces making the disinfection and cleaning of patient care areas essential in preventing the 
transmission of MRSA. 
Adequate cleaning requires the removal of pathogens to minimize patients' risks of 
acquiring MRSA through the hospital environment. Although sterilization of the environment is 
not the goal, certain measures help increase the removal of MRS A. Bed curtains are usually the 
first to be touched after examining a patient and before performing hand hygiene. Therefore, 
exchanging bed curtains after discharging patients with MRSA becomes a critical measure to 
reduce MRSA transmission. However, many hospitals today often utilize off-site laundry 
Reducing MRSA 14 
services and have a paucity of extra bedside curtains, making this measure challenging in the 
current state of healthcare. Another critical measure to increase the removal of MRSA is the use 
of pour bottles instead of spray bottles, which will ensure that larger quantities are applied to 
surfaces (Goodman eta!, 2008). According to the IHI (2008) standard, EPA approved 
environmental disinfectants are recommended for the removal of MRSA. What may be more 
important than the type of disinfectant used is the actual physical scrubbing and wiping of the 
surface (Healthcare Infection Control Practices Advisory Committee, 2003). 
With hospitals under tight budget restrictions it is not realistic to hire more 
environmental services people to enhance hygiene. Instead, hospitals should be using training 
and education as a means to increase the knowledge base of the employees they already have. 
The Society for Healthcare Epidemiology of America (SHEA) guidelines advocate for staff 
education, checklists, and frequent, scheduled cleaning times. Evanston N orthwestem Hospital in 
Illinois currently uses a checklist instead of asking staff to rely on memory (Appendix A). 
Active Surveillance Cultures & Contact Precautions 
Patients colonized with MRSA serve as a major reservoir for its spread within the 
healthcare environment and are as likely to contaminate the environment as those who are 
infected (Clancy et al, 2006). Colonization can occur in a hospital, another healthcare facility 
such as a nursing home or long term care facility, or even in the community. Patients from long 
term care, rehab, or a chronic care facility are most at risk for colonization of MRSA. In 2003, 
SHEA published guidelines for preventing the transmission of MRS A. The primary 
recommendation of these guidelines stated that all patients with a high risk of carrying MRSA 
should be tested using active surveillance cultures (ASCs) upon admission to a healthcare facility 
to prevent patient-to-patient transmission and then implement contact precautions (Society for 
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Healthcare Epidemiology of America, 2003). SHEA also notes that the countries that have had 
the most success in controlling MRSA are ones that have instituted ASCs and the strict 
application of contact precautions. In Denmark, the prevalence ofMRSA peaked to 30% in the 
1960s, but has maintained at less than one percent for 25 years after the introduction of a policy 
to control transmission. In Finland and the Netherlands, the prevalence of MRSA has maintained 
at lower than one-half percent (Hall & Flay hart, 2006). 
The anterior nares are the most sensitive body site for assessing MRSA colonization and 
remain the preferred site for ASCs (Furuno et al, 2007). According to the IHI (2008), ASCs of 
the nares will identify 80% of colonized patients. It is imperative to differentiate between MRSA 
colonization and active infection when discussing the importance of ASCs. MRSA is often found 
on the skin and mucosal surfaces of humans without producing signs and symptoms of infection. 
This is known as colonization. However, when there is a breakdown in the defenses of the host, 
whether physical or immunological, these colonizing bacteria become capable of producing 
infection, sometimes even death. In fact, various studies have demonstrated a 10-30% incidence 
of MRSA colonization resulting in infection, which is higher for those severely ill than non-
acutely ill patients (Weber et al, 2007). Patients with active MRSA infections are only a small 
percentage of the millions of people who are colonized and without symptoms- the Iceberg 
Effect (Buscell, 2006). Due to the large population of colonized and asymptomatic patients, it is 
critical to identify upon admission and properly isolate them with the appropriate precautions to 
prevent transmission to other patients. 
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Any plan to institute ASCs should be done in consultation with the laboratory. The 
financial impact on the laboratory will be determined by the extent to which the healthcare 
institution implements ASCs-whether they perform them on all patients admitted to the facility 
or just the high risk patients or patients admitted from long term care facilities. The cost to the 
facility will also depend on the type of test they choose. A test with a two hour turnaround time 
is much more costly to the institution than one with a 48 hour turnaround time. However, since 
ASCs are designed to guide the intervention of implementing contact precautions for colonized 
patients, the chosen screening test should have a turnaround time of 24 hours or less (Diekema & 
Edmond, 2007). Whether an institution chooses a test with a two-hour turnaround time or one 
with a 24-hour turnaround time, the overall savings as a result of early detection of MRSA and 
the further prevention of infection and transmission to other patients outweighs the added 
expense ofthe ASC program itself(Weber et al, 2007). A study conducted by Karchmer, Durbin, 
Simonton, & Farr (2002) demonstrated that the prevention of nosocomial MRSA bloodstream 
infections ultimately cost less than the ASCs. 
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After identifying MRSA colonization the institution must decide whether or not to 
decolonize the patient. The purpose of decolonization is to eradicate the carriage of the pathogen 
to prevent infection in the colonized patient and prevent the transmission ofMRSA to others. 
The decolonization process includes a topical mupirocin either alone or in combination with an 
oral antibiotic and antimicrobial soap for bathing, usually chlorhexidine (Centers for Disease 
Control and Prevention, 2006). Currently, the CDC and APIC do not support the decolonization 
of patients due to the fact that over time decolonized persons often become recolonized. 
Contact precautions is the physical separation of colonized or infected patients from other 
patients plus HCWs wearing a gown to serve as a barrier between them and the patient. HCWs 
are at risk for contaminating their clothes when they have substantial contact with colonized or 
infected patients, and then in turn could contaminate their hands when they touch their clothes. 
This could increase the risk of transmission ofMRSA from HCWs to patients. Wearing gowns 
and gloves when caring for a MRSA colonized or infected patient is an essential component of 
preventing transmission and is recommended by HICPAC. In fact, patients who are colonized or 
infected with MRSA but do not have contact precautions in place are 16 times as likely to 
transmit MRSA to other patients and healthcare workers (Clancy et al, 2006). In addition to 
gowns and gloves, placing patients in a private room will make it less likely that a HCW will 
move from a colonized or infected patient to an uncolonized patient before performing hand 
hygiene. Cohorting patients with MRSA is an acceptable practice when private rooms are not 
available. Failure to follow contact precautions could potentially undo the benefit of an active 
surveillance program (Institute for Healthcare Improvement, 2008). 
The question of when to implement and discontinue contact precautions remains an 
unresolved issue. There are two options when implementing contact precautions- they can be 
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preemptive- implemented upon admission and continued until the culture comes back negative 
for MRSA, or they can be implemented only after receiving a positive culture result, which could 
take up to one to two days depending on the test. In a study done at the Brigham and Women's 
Hospital in Boston, Massachusetts, Huang et al (2006) found that even with a two-day delay for 
cultures to return, their surveillance had a significant impact on MRSA transmission and 
infection. It is often logistically challenging for healthcare institutions to implement preemptive 
precautions due to bed management issues, so if they are unable to do this utilizing an ASC with 
a two-hour turnaround time would decrease the exposure time if the culture is positive. 
Currently, there are no official recommendations from HICP AC and experts tend to disagree on 
when to discontinue precautions because it is possible for patients to remain colonized with 
MRSA for months to years. However, in the context of an outbreak, it is recommended that 
contact precautions be used indefinitely for all infected and colonized patients (Center for 
Disease Control and Prevention, 2006). The IHI has made recommendations for three negative 
cultures on separate days before discontinuing precautions in addition to being off antibiotic 
therapy (Institute for Healthcare Improvement, 2008). 
Patients who are on contact precautions deserve the same level of care as any other 
patient in the hospital. However, some studies have shown a 50% reduction in contact between 
patients on precautions and HCWs, including a reduction in physician examinations (Diekema & 
Edmond, 2007). Patients in isolation can also have increased feelings of isolation and loss of 
control, which can ultimately result in anxiety and depression. Involving the patient in decisions 
about their treatment plans and providing extra social support through social work, psychology, 
and physical and occupational therapy may reduce this effect (Diekema & Edmond, 2007). 
Device Bundles 
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Invasive devices such as central venous catheters (CVCs) and ventilators are historically 
known to predispose already critically ill patients to infections. Furthermore, patients who are 
colonized with MRSA are at even more risk of developing a bloodstream infection or 
pneumonia. The IHI has developed information about "bundles" which are groupings of 
evidenced-based best practices that individually improve care, but when applied together result 
in even more improvement (Institute for Healthcare Improvement, 2008). Through the 
implementation of these "bundles" the incidence of hospital-acquired infections associated with 
invasive devices can significantly be reduced as well as the associated costs and prolonged 
hospitalizations. Many hospitals that are currently using these Central Line and Ventilator 
Bundles have seen a significant reduction in central line bloodstream infections and ventilator-
associated pneumonias (Griffin, 2007). 
Central venous catheters are being used more and more in the hospital setting. According 
to the IHI (n.d.) 48% ofiCU patients have CVCs resulting in approximately 5.3 central line 
infections per 1,000 catheter days and an 18% mortality rate. This amounts to about 14,000 
deaths per year as a result of central line infections. The central line bundle has five key 
components: 1) hand hygiene 2) maximal barrier precautions 3) chlorhexidine skin antisepsis 4) 
optimal catheter site selection, with subclavian vein being the preferred site for non-tunneled 
catheters 5) daily review of line necessity, with prompt removal of unnecessary lines (Institute 
for Healthcare Improvement, n.d.). 
As continually discussed throughout this paper, hand hygiene is a major component to 
decreasing central line infections. When caring for central lines, practitioners should be sure to 
perform hand hygiene before and after palpating the insertion site and inserting or replacing the 
catheter as well as performing dressing changes (Institute for Healthcare Improvement, n.d.). 
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In regards to maximal barrier precautions, the person inserting the catheter as well as 
anyone assisting should be wearing a cap, mask, sterile gown, and gloves. In addition, the 
patient should be covered with a sterile drape from head to toe, with only a small opening for the 
insertion site. 
Chlorhexidine skin antisepsis has been proven to be more effective in reducing central 
line bloodstream infections than povidone-iodine solutions. In fact, in 2002 a meta-analysis 
reviewed eight studies and found a 49% reduction rate in catheter-related bloodstream infections 
whose skin was prepped with chlorhexidine (Milstone, Passaretti, & Perl, 2008). 
The site of the catheter placement is a risk factor in relation to catheter-associated 
infections. Studies have shown a decrease in infection rates with the use of the subclavian site 
over the femoral or jugular. When not contraindicated, the subclavian site is the preferred site for 
central line insertion over any other (Institute for Healthcare Improvement, n.d. ). 
Lastly, the longer a central line is in, the greater risk of developing an infection as a result 
of that line. Therefore, a daily review of its need should be done to prevent delays in removing 
the line when it is no longer indicated, therefore decreasing the risk of developing a central line 
infection. In addition, CDC guidelines (2002) do not support' the arbitrary replacement of central 
lines, as it has not proven to reduce central line infections. 
Ventilator-associated pneumonia (V AP) is the leading cause of death among patients 
with hospital-acquired infections, even surpassing central line infections in death rates. In 
addition to increased mortality, V AP has a huge financial impact on healthcare institutions as a 
result of an increase in patient stay. Similarly to the central line bundle, the ventilator bundle 
consists of four evidence-based components that have proven to reduce the incidence of V AP: I) 
elevation of the head of the bed between 30 and 45 degrees 2) daily "sedation vacation" and a 
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daily assessment of a patient's readiness to extubate 3) Peptic Ulcer Disease (PUD) prophylaxis 
4) deep venous thrombosis (DVT) prophylaxis (Institute for Healthcare Improvement, n.d.). 
The aspiration of infected oral and gastric secretions plays a large role in the development 
ofVAP. Many studies have found that placing the head of bed of ventilated patients at a 45-
degree angle can significantly reduce the incidence ofVAP (Keeley, 2007). In addition to 
reducing the risk of aspiration, elevating the head of bed 30 to 45 degrees improves ventilation, 
which can also decrease the risk ofVAP. Daily "sedation vacations" and assessing a patient's 
readiness to extubate play a significant role in the reduction of V AP. Decreasing sedation not 
only reduces the risk ofV AP, but it also helps the patient to be more awake and alert and able to 
participate in the extubation process. 
Ventilated patients are at increased risk of aspiration and aspirating acidic gastric 
contents can result in pneumonia, which can be prevented by instituting PUD prophylaxis. The 
Surviving Sepsis Campaign Guidelines has stated that H2 receptor inhibitors are more effective 
in fighting Peptic Ulcer Disease than sucralfate, and are the treatment of choice (Dellinger et a!, 
2004). 
Currently, it is important to point out that some practices included in the prevention 
bundles, such as instituting DVT prophylaxis and head of bed elevation, have not been proven in 
the literature to improve patient outcomes. A systematic review of the evidence that supports 
bundle practices, published by the Stanford-UCSF Evidence-based Practice Center in 2001, 
evaluated a number of such infection control practices. According to this review, the practice of 
the use of maximal sterile barriers during central line insertions was assessed to have the 
strongest evidence base, while further research is needed for many other infection control 
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recommendations (Y okoe & Classen, 2008). However, the IHI believes that including these 
practices in the bundles can only positively affect the outcome of patients. 
To Mandate or Not Mandate-- A Legislative Debate 
The mandate of public reporting and active surveillance cultures (ASCs) for MRSA has 
been said to be incentive for healthcare institutions to provide better care and provide consumers 
with the necessary knowledge to choose safe and quality healthcare. Furthermore, the concern 
about the rising incidence of MRSA in healthcare institutions has prompted lawmakers in many 
states to push hospitals to institute ASCs to facilitate early diagnosis and prevent further 
transmission. Currently, three states- Illinois, New Jersey, and Pennsylvania- have passed laws 
mandating hospitals perform ASCs upon admission and similar laws have been proposed in 
seven other states and the District of Columbia. This has led to much debate amongst 
professional organizations such as APIC and SHEA and consumer groups such as the Consumers 
Union and the Committee to Reduce Infection Deaths, with the latter groups being the push for 
legislative mandates. 
The Commonwealth of Massachusetts is conducting a two-part point prevalence study in 
2008 to capture a snapshot of the current MRSA situation in its ICUs. During two designated 
weeks set by the state, ICUs across the Commonwealth are to perform ASCs on every patient in 
the ICU at that time. Infection Prevention Coordinators across the Commonwealth must then 
relay their facility's results to the Department of Public Health. With these results the 
Commonwealth will be able to set standards and guidelines for hospitals to reduce the prevalence 
ofMRSA. 
According to SHEA, the high rate of morbidity and mortality associated with MRSA 
infections in the hospital may not be attributed to increased virulence of resistant strains, but to 
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delays in the appropriate antimicrobial therapy (Calfee et. a!., 2008). Early detection through 
ASCs enables healthcare providers to provide the appropriate antimicrobial therapy and institute 
contact precautions and isolation to prevent further transmission. 
While APIC and SHEA believe ASCs are a vital component to reducing MRSA 
transmission, at this time, they do not support legislation to mandate them. Both organizations 
are concerned that states will not allocate additional resources to hospitals to support the added 
responsiblities from implementing an ASC program. Without additional support, infection 
prevention professionals and healthcare epidemiologists will be obligated to commit themselves 
to this process, which could lead to worsening rates of other healthcare-associated infections 
(Weber et. a!, 2007). Additionally, it would remove the needed expertise of infection prevention 
professionals from the risk assessment and resource allocation processes needed to meet the 
epidemiological challenges of each individual healthcare institution (Weber et. a!, 2007). 
Logistically, hospitals could potentially find themselves with a patient placement 
dilemma since most facilities are not equipped with all single patient rooms. Hospitals will 
experience an increase in MRSA patients as a result of ASCs, which will require proper 
isolation, usually in a private room. Although cohorting patients is an alternative, this too can 
pose problems logistically by delaying hospital admissions, transfers within the facility, and 
discharges to outside facilities such as rehabilitation or long term care. 
Both organizations support the use of ASCs but believe that mandating them and using 
them as the only intervention to control the transmission of MRSA is unlikely to be effective. It 
needs to be a decision made by each individual facility with a multifaceted/multidisciplinary 
approach that includes timely notification from the laboratory once patients are identified with 
MRSA, placing the patient on contact precautions and in isolation, and proper hand hygiene and 
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disinfection of equipment and the environment. The "one-size fits all" approach of legislation 
does not provide the flexibility needed to respond to epidemiological trends or changes in the 
understanding of transmission. 
Many states are also mandating hospitals report monthly statistics related to hospital-
acquired infections to the CDC through the National Healthcare Safety Network (NHSN). The 
National Healthcare Safety Network (NHSN) is a secure, internet-based surveillance system that 
integrates patient and healthcare personnel safety surveillance systems managed by the Division 
of Health care Quality Promotion (DHQP) at CDC. This reporting will allow the states to 
estimate the magnitude of adverse events among patients and HCWs and recognize trends. 
Although this system provides important data on the magnitude of adverse events among patients 
and HCWs and trends, it requires Infection Preventionists to manually import data into the 
system, which takes up valuable time that could be used to educate staff and implement new 
strategies to reduce infections. 
Recommendations 
I. Form a multidisciplinary Hand Hygiene Task Force comprised of stafffrom 
nursing, dietary, and environmental services to conduct surveillance on patient 
care units and determine current compliance rates. Make hand hygiene a 
positive part of the culture. Conduct educational sessions with staff to 
demonstrate correct technique and emphasize the importance of hand hygiene. 
2. Show the CDC's Hand Hygiene Saves Lives video to patients during their 
hospitalization. 
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3. Educate environmental services and nursing staff on proper decontamination of 
the environment and equipment. Utilize a checklist to eliminate performance by 
memory. Perform cleaning with an EPA approved disinfectant daily and upon 
patient discharge. Replace bedside curtains upon discharge. 
4. Increase staff access to waterless alcohol-based hand hygiene products. 
5. Implement contact precautions and isolation for all patients with a known 
history of MRSA for the duration of their hospitalization. 
6. Initiate the central line and ventilator bundles into patient care. 
7. Conduct ASCs upon admission on ail ICU patients and patients from long term 
care facilities, rehabilitation facilities, and chronic care hospitals. Utilize a 
medium with a 24-hour turnaround time for rapid diagnosis. 
8. Do not decolonize patients. 
Conclusion 
The emergence ofMRSA in healthcare has occurred rapidly and continues to be on the 
rise. The reduction of transmission within a healthcare institution will not occur with a single 
intervention, rather a combination of all interventions mentioned in this paper. Infection 
Prevention leaders must decide how and to what degree to implement these strategies in their 
facilities because each healthcare institution is unique and has different financial and educational 
needs. Often, healthcare institutions cannot implement all five components recommended in this 
paper at the same time due to financial constraints, but research has shown that each component 
plays a significant role in reducing infections and should be implemented at some point. 
Therefore, a good leader will do a risk assessment of the facility to determine its needs, and 
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convene a group with representatives from Environmental Services, Medical Staff, Staff 
Nursing, Nursing Administration, Hospital Administration, and Quality. It is also important in 
every aspect of implementation to recruit a Physician Champion- a medical leader that will 
actively support the mission of the group. Then, based on evidence-based practice and research, 
this group will work to implement the interventions necessary to reduce the incidence of MRSA, 
whether it's done one by one or simultaneously. 
As a result of Medicare's decision to not reimburse facilities for many healthcare-
acquired infections, infection prevention has become a top priority for many hospital 
administrators. Finally they are listening, and in many facilities are allocating the necessary 
resources to reduce infections. Infection Preventionists must take this opportunity to determine 
the priorities for their institutions and implement the necessary interventions to reduce MRSA 
infections. 
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Appendix A 
ENVIRONMENTAL SERVICES CHECK LIST AUDIT 
DAILY CLEANING OF PATIENT ROOM 
1. High Dusting Performed 
a. Use high duster/mop head: wipe ledges 
(shoulder high and above) 
b. Vents 
c. Lights 
*Do not high dust OVER the patient* 
d. Dust TV: rotate and dust screen and wires 
*Remove dust over cart trash bag gently* 
2. Damp Dust 
Cloth (rag) and spray bottle of disinfectant 
-damp wipe: 
a. Ledges (shoulder high) 
b. Door handles 
3. Bedside Table- Disinfect Surface 
4. Glass Surfaces 
a. Wall spots 
N/A 
STEPS 
5. Bathroom (Toilet Bowl Mop) All Surfaces 
a. Weekly toilet chemical allow to stay 
b. Ledges in bathroom 
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e. Shower stall Yes No 
f. Finish toilet Yes No 
g. Damp wipe toilet seat Yes No 
-
h. Clean mirrors/chrome Yes No 
- -
6. Empty Waste Basket Yes No 
-
-
a. Disinfect if wet Yes No 
b. Bags- close Yes No 
7. Isolation (Red Bag Waste) Empty Yes No 
-
a. Carry to soiled utility room Yes No 
-
b. Carry to Large Red Hazard trash Yes 
-
No 
8. Needle Boxes 
a. Check level of Sharps Yes No 





c. To soiled Utility Room after securely closing Yes No 
-
N/A 
9. Floor Disinfection- Sign on Door 
a. Wet mop head in disinfectant Yes No 
b. Mop (farthest from door) Yz way room Yes No 
c. Bathroom shower floor Yes No 
d. Bathroom floor Yes No 
- -
e. Flip mop head - do remainder of room Yes No 
-
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